Ironwood Pharmaceuticals | IRWD - Costo Del Venduto

Prezzo Delle Azioni
3.04
Cambio Giornaliero
-0.19 -5.88%
Mensile
-18.93%
Annuale
115.60%
Q1 Previsione
2.95




Costo Del Venduto Cambiamento Data
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.88M 199K 2025-12
Akebia Therapeutics USD 10.34M 441K 2025-12
Almirall EUR 191.5M 2.29M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Astellas Pharma JPY 149.13B 10.88B 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Coherus Biosciences USD 4.04M 324K 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Exact Sciences USD 266.81M 18.18M 2025-09
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Incyte USD 121.18M 22.18M 2025-12
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
Lexicon Pharmaceuticals USD 201K 191K 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Moderna USD 452M 245M 2025-12
Myriad Genetics USD 63M 1.1M 2025-12
Pacira USD 54.62M 6.02M 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12